MedPath

Societal Burden Associated With Type 1 Diabetes in Canada

Recruiting
Conditions
Type 1 Diabetes Mellitus
Quality of Life (QOL)
Work Productivity
Caregiver Subjective Burden
Registration Number
NCT06786130
Lead Sponsor
PeriPharm
Brief Summary

The purpose of this observational study is to estimate the burden of T1D on caregivers of patient with T1D in terms of work productivity, healthcare resource utilization and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Parental caregiver of a child recently diagnosed (<= 2 years) with T1D before study inclusion;
  2. Age ≥18 ;
  3. Residence in the Canada;
  4. Willingess to complete a 20-minute survey
  5. Ability to read and understand French or English;
  6. Signature of informed consent form (ICF)
Exclusion Criteria
  1. Participation in a clinical trial.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To estimate work productivity impairment of caregivers of a T1D child.At recruitment

Using the WOrk Productivity and Activity Impairment (WPAI) questionnaire

Secondary Outcome Measures
NameTimeMethod
To estimate healthcare resource utilization in caregivers of T1D childAt recruitment

Using the modified Resource Utilization Questionnaire for Type 1 Diabetes (mRUQ-T1DM) questionnaire.

To estimate health-related quality of life in caregivers of a T1D childAt recruitment

Using the EuroQOL-5 dimension-5 levels (EQ-5D-5L) questionnaire.

To estimate the caregiver burden in caregivers of a T1D childAt recruitment

Using the Zarit Burden Interview-22 (ZBI-22) questionnaire.

Trial Locations

Locations (1)

PROxy Network, an initiative of PeriPharm Inc.

🇨🇦

Montreal, Quebec, Canada

PROxy Network, an initiative of PeriPharm Inc.
🇨🇦Montreal, Quebec, Canada
Catherine Beauchemin, PhD
Contact
514-731-8207
catherine.beauchemin@peripharm.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.